ALFA Filings
Every announcement, straight from the exchange
Every Cohance Lifesciences business update announcement on NSE and BSE, newest first, each with its own page.
Time
4 announcements
Cohance Lifesciences completed a USFDA inspection at its Jaggaiahpet API facility, receiving a Form 483 with five observations. The company has initiated corrective and preventive actions.
Cohance Lifesciences completed a USFDA inspection of its Shamshabad formulation plant, receiving a Form 483 with four observations. The company is initiating corrective measures.
Cohance Lifesciences has submitted its Business Responsibility and Sustainability Report (BRSR) for FY 2025-26 in compliance with SEBI regulations. The report is available on the website.
Cohance Lifesciences completed a USFDA inspection at its Pashamylaram facility, receiving five observations in Form FDA 483. None of the observations relate to data integrity issues.